+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID05699005

Comparing Personalized and Standard Blood Transfusion Strategies for Patients on Peripheral VA-ECMO with Refractory Cardiogenic Shock

Led by University Hospital, Lille · Updated on 2026-09-17

236

Participants Needed

4

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare two strategies for red blood cell transfusion in patients receiving veno-arterial extracorporeal membrane oxygenation VA-ECMO support for refractory cardiogenic shock. The study evaluates whether an individualized approach based on central venous oxygen saturation ScVO2 is more effective in reducing blood transfusion compared to a conventional method using a predefined hemoglobin threshold. This multicenter randomized controlled trial focuses on red blood cell consumption, mortality, morbidity, and cost-effectiveness in this critical patient group. Participants will be assigned to one of two groups an individualized transfusion strategy where transfusions occur if ScVO2 drops below 65% after optimizing oxygen saturation, volume, ECMO output, fever, anxiety, and pain or a conventional strategy where transfusions are given if hemoglobin levels fall below 9 gdL. Transfusions may also be performed in both groups under specific conditions such as massive bleeding, STEMI, hyperlactatemia, low hemoglobin below 7 gdL, or worsening neurological condition related to oxygen delivery. During the study, participants will be monitored closely with assessments of red blood cell transfusion amounts per day, hemoglobin and ScVO2 levels, mortality rates up to 90 days, and other clinical outcomes including organ function and complications. The study includes laboratory tests, clinical evaluations, and cost-effectiveness analyses. Monitoring continues from randomization until ECMO weaning, with follow-up assessments extending to 90 days and beyond, ensuring comprehensive evaluation of patient outcomes and safety.

CONDITIONS

Brief Title

Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO

Research Team

M

Mouhamed MOUSSA, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here